ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
Clinical trial NCT02943720 · COMPLETED
Trial details
- NCT number
- NCT02943720
- Sponsor
- Anergis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-07-01
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.